The median number of days in hospital per patient (total days of hospitalization during follow up) was 6.0 (IQR 3.0–12.0) for all patients, with a decreasing trend comparing hATTR-CM reference (6.0 days [IQR 3.0–12.0]) to hATTR-CM-like (4.0 days [IQR 1.0–10.5] ( Table 6 ).
← all excerpts
Assessment of potential transthyretin amyloid cardiomyopathy cases in the Brazilian public health system using a machine learning model.
1
—
—